0001209191-15-079481.txt : 20151112 0001209191-15-079481.hdr.sgml : 20151112 20151112073535 ACCESSION NUMBER: 0001209191-15-079481 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151111 FILED AS OF DATE: 20151112 DATE AS OF CHANGE: 20151112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Endo International plc CENTRAL INDEX KEY: 0001593034 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MINERVA HOUSE, SIMMONSCOURT ROAD STREET 2: BALLSBRIDGE CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 353-1-268-2000 MAIL ADDRESS: STREET 1: MINERVA HOUSE, SIMMONSCOURT ROAD STREET 2: BALLSBRIDGE CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Endo International Ltd DATE OF NAME CHANGE: 20131203 FORMER COMPANY: FORMER CONFORMED NAME: Sportwell Ltd DATE OF NAME CHANGE: 20131126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campanelli Paul CENTRAL INDEX KEY: 0001392459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36326 FILM NUMBER: 151221431 MAIL ADDRESS: STREET 1: C/O PAR PHARMACEUTICAL COMPANIES, INC. STREET 2: ONE RAM RIDGE ROAD CITY: CHESTNUT RIDGE STATE: NY ZIP: 10977 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-11-11 0 0001593034 Endo International plc ENDP 0001392459 Campanelli Paul C/O ENDO INTERNATIONAL PLC MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN 4 L2 00000 IRELAND 0 1 0 0 President, Par Pharmaceutical Ordinary Shares 2015-11-11 4 P 0 1900 55.62 A 187869 D Ordinary Shares 2015-11-11 4 P 0 200 56.38 A 188069 D Stock Incentive Plan Performance Shares 2015-11-11 4 A 0 2100 A 105466 D Stock Incentive Plan Restricted Stock Units (RSU) 15367 D This represents the average price per share of ordinary shares that Mr. Campanelli bought on the open market on November 11, 2015 at prices ranging from $55.22 to $56.17. This represents the average price per share of ordinary shares that Mr. Campanelli bought on the open market on November 11, 2015 at prices ranging from $56.34 to $56.41. The performance shares vest upon the Company achieving certain shareholder return targets over a cumulative 3-year period. Represents the target number of shares issuable upon achievement of a certain shareholder return target over a cumulative 3-year period, as determined by the Registrant's Board of Directors at the end of such three-year period. The ultimate number of shares issued may be the target number or zero, depending on the Registrant's attainment of the shareholder return target over the period. Pursuant to the Endo International plc Matched Performance Share Unit Program, the Registrant matched Mr. Campanelli's open market purchases of ordinary shares, subject to certain limitations, which occurred on November 11, 2015, as reported above. These securities were granted to Mr. Campanelli in consideration of his services as the President, Par Pharmaceutical of Endo International plc. Represents the cumulative target quantity of shares issuable with respect to all 2010 and 2015 Stock Incentive Plan performance shares outstanding. The cumulative total is the combination of the target payouts for the current grant and all past grants made under the 2010 Stock Incentive Plan and the 2015 Stock Incentive Plan and still outstanding, which are subject to a range of payouts depending on the achievement of certain performance metrics as described herein for the current grant and as previously disclosed for all other performance share grants. Subject to time-based vesting, each restricted stock automatically converts into one (1) ordinary share of Endo International plc. /s/ Matthew J. Maletta, by Power of Attorney 2015-11-12